Literature DB >> 7500018

A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells.

S Malarkannan1, M Afkarian, N Shastri.   

Abstract

The identity of allogeneic peptide/major histocompatibility complex (MHC) complexes that elicit vigorous T cell responses has remained an interesting problem for both practical and theoretical reasons. Although a few abundant MHC class I-bound peptides have been purified and sequenced, identifying the unique T cell-stimulating peptides from among the thousands of existing peptides is still a very difficult undertaking. In this report, we identified the antigenic peptide that is recognized by an alloreactive bm1 anti-B6 T cell clone using a novel genetic strategy that is based upon measurement of T cell receptor occupancy in single T cells. Using lacZ-inducible T cells as a probe, we screened a splenic cDNA library in transiently transfected antigen-presenting cells (APCs) and isolated a cDNA clone that allowed expression of the appropriate peptide/Kb MHC complex in APC. The antigenic octapeptide (SVVEFSSL) exactly matched the consensus Kb MHC motif, but was surprisingly encoded by a non-ATG defined translation reading frame. Furthermore, the abundance of the naturally processed analog in untransfected cells was estimated to be <10 copies per cell. These results illustrate a novel strategy for identifying T cell-stimulating antigens in general and directly show that alloreactive T cells can respond to rather rare peptide/MHC complexes. These results also suggest that the total pool of processed peptides expressed on the APC surface may include those generated by cryptic translation of normally expressed transcripts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500018      PMCID: PMC2192241          DOI: 10.1084/jem.182.6.1739

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

Review 1.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen.

Authors:  C J Aldrich; A DeCloux; A S Woods; R J Cotter; M J Soloski; J Forman
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

3.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

4.  Source of unique tumour antigens.

Authors:  A Townsend; C Ohlén; M Rogers; J Edwards; S Mukherjee; J Bastin
Journal:  Nature       Date:  1994-10-20       Impact factor: 49.962

5.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

6.  The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.

Authors:  J M Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 7.  Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications.

Authors:  S G Nathenson; J Geliebter; G M Pfaffenbach; R A Zeff
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

Review 8.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. Implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects.

Authors:  N Shastri; A Oki; A Miller; E E Sercarz
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.

Authors:  A Uenaka; T Ono; T Akisawa; H Wada; T Yasuda; E Nakayama
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  18 in total

1.  Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues.

Authors:  Corbett J A Reinbold; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

Review 2.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

3.  Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.

Authors:  T E Sparer; S G Wynn; D J Clark; J M Kaplan; L M Cardoza; S C Wadsworth; A E Smith; L R Gooding
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli.

Authors:  Sharanya Prasad; Shelley R Starck; Nilabh Shastri
Journal:  J Immunol       Date:  2016-09-19       Impact factor: 5.422

Review 5.  Tumor antigens discovery: perspectives for cancer therapy.

Authors:  R F Wang
Journal:  Mol Med       Date:  1997-11       Impact factor: 6.354

6.  The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma.

Authors:  S Malarkannan; T Serwold; V Nguyen; L A Sherman; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

8.  Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Authors:  Charles T Spencer; Jelena S Bezbradica; Mireya G Ramos; Chenoa D Arico; Stephanie B Conant; Pavlo Gilchuk; Jennifer J Gray; Mu Zheng; Xinnan Niu; William Hildebrand; Andrew J Link; Sebastian Joyce
Journal:  Proteomics Clin Appl       Date:  2015-12       Impact factor: 3.494

Review 9.  Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.

Authors:  Shelley R Starck; Nilabh Shastri
Journal:  Immunol Rev       Date:  2016-07       Impact factor: 12.988

10.  CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level.

Authors:  Kerstin Göbel; Stefan Bittner; Nico Melzer; Susann Pankratz; Angela Dreykluft; Michael K Schuhmann; Sven G Meuth; Heinz Wiendl
Journal:  J Neuroinflammation       Date:  2012-02-28       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.